Parkinson's disease (PD) is most commonly manifested by the presence of motor symptoms. However, non-motor symptoms occur several years before the onset of motor symptoms themselves. Hallmarks of dysfunction of the respiratory system are still outside the main focus of interest, whether by clinicians or scientists, despite their indisputable contribution to the morbidity and mortality of patients suffering from PD. In addition, many of the respiratory symptoms are already present in the early stages of the disease and efforts to utilize these parameters in the early diagnosis of PD are now intensifying. Mechanisms that lead to the development and progression of respiratory symptoms are only partially understood. This review focuses mainly on the comparison of respiratory problems observed in clinical studies with available findings obtained from experimental animal models. It also explains pathological changes observed in non-neuronal tissues in subjects with PD.

Biomedical Center Martin Jessenius Faculty of Medicine in Martin Comenius University Bratislava Martin Slovak

Zobrazit více v PubMed

ANDRZEJEWSKI K, BUDZINSKA K, KACZYNSKA K. Effect of 6-OHDA on hypercapnic ventilatory response in the rat model of Parkinson’s disease. Physiol Res. 2019;68:285–293. doi: 10.33549/physiolres.933949. PubMed DOI

ANTOSOVA M, MOKRA D, PEPUCHA L, PLEVKOVA J, BUDAY T, STERUSKY M, BENCOVA A. Physiology of nitric oxide in the respiratory system. Physiol Res. 2017;66(Suppl 2):S159–S172. doi: 10.33549/physiolres.933673. PubMed DOI

ASKANAS V, ENGEL WK, ALVAREZ RB, McFERRIN J, BROCCOLINI A. Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions. J Neuropathol Exp Neurol. 2000;59:592–598. doi: 10.1093/jnen/59.7.592. PubMed DOI

BAILLE G, PEREZ T, DEVOS D, DEKEN V, DEFEBVRE L, MOREAU C. Early occurrence of inspiratory muscle weakness in Parkinson’s disease. PLoS One. 2018;13:e0190400. doi: 10.1371/journal.pone.0190400. PubMed DOI PMC

BATEMAN DN, COOPER RG, GIBSON GJ, PEEL ET, WANDLESS I. Levodopa dosage and ventilatory function in Parkinson’s disease. Br Med J (Clin Res Ed) 1981;283:190–191. doi: 10.1136/bmj.283.6285.190-a. PubMed DOI PMC

BEACH TG, ADLER CH, SUE LI, VEDDERS L, LUE L, WHITE CL, III, AKIYAMA H, CAVINESS JN, SHILL HA, SABBAGH MN, WALKER DG ARIZONA PARKINSON’S DISEASE C. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119:689–702. doi: 10.1007/s00401-010-0664-3. PubMed DOI PMC

BOUKHENOUNA S, WILSON MA, BAHMED K, KOSMIDER B. Reactive oxygen species in chronic obstructive pulmonary disease. Oxid Med Cell Longev. 2018;2018:5730395. doi: 10.1155/2018/5730395. PubMed DOI PMC

BRAAK H, del TREDICI K, RUB U, de VOS RA, JANSEN STEUR EN, BRAAK E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211. doi: 10.1016/S0197-4580(02)00065-9. PubMed DOI

de BRUIN PF, de BRUIN VM, LEES AJ, PRIDE NB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson’s disease. Am Rev Respir Dis. 1993;148:1576–1580. doi: 10.1164/ajrccm/148.6_Pt_1.1576. PubMed DOI

de PANDIS MF, STARACE A, STEFANELLI F, MARRUZZO P, MEOLI I, de SIMONE G, PRATI R, STOCCHI F. Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurol Sci. 2002;23(Suppl 2):S69–S70. doi: 10.1007/s100720200074. PubMed DOI

DEAN JB, LAWING WL, MILLHORN DE. CO2 decreases membrane conductance and depolarizes neurons in the nucleus tractus solitarii. Exp Brain Res. 1989;76:656–661. doi: 10.1007/BF00248922. PubMed DOI

EBIHARA S, SAITO H, KANDA A, NAKAJOH M, TAKAHASHI H, ARAI H, SASAKI H. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;124:1009–1015. doi: 10.1378/chest.124.3.1009. PubMed DOI

EREKAT NS. Apoptotic Mediators are Upregulated in the Skeletal Muscle of Chronic/Progressive Mouse Model of Parkinson’s Disease. Anat Rec (Hoboken) 2015;298:1472–1478. doi: 10.1002/ar.23124. PubMed DOI

ESTENNE M, HUBERT M, de TROYER A. Respiratory-muscle involvement in Parkinson’s disease. N Engl J Med. 1984;311:1516–1517. doi: 10.1056/NEJM198412063112314. PubMed DOI

FELDMAN JL, MITCHELL GS, NATTIE EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci. 2003;26:239–266. doi: 10.1146/annurev.neuro.26.041002.131103. PubMed DOI PMC

FINBERG JPM, SCHWARTZ M, JERIES R, BADARNY S, NAKHLEH MK, ABU DAOUD E, AYUBKHANOV Y, ABOUD-HAWA M, BROZA YY, HAICK H. Sensor Array for Detection of Early Stage Parkinson’s Disease before Medication. ACS Chem Neurosci. 2018;9:2548–2553. doi: 10.1021/acschemneuro.8b00245. PubMed DOI

FONTANA GA, PANTALEO T, LAVORINI F, BENVENUTI F, GANGEMI S. Defective motor control of coughing in Parkinson’s disease. Am J Respir Crit Care Med. 1998;158:458–464. doi: 10.1164/ajrccm.158.2.9705094. PubMed DOI

FU Q, SONG R, YANG Z, SHAN Q, CHEN W. 6-Hydroxydopamine induces brain vascular endothelial inflammation. IUBMB Life. 2017;69:887–895. doi: 10.1002/iub.1685. PubMed DOI

GOMEZ-SUAGA P, BRAVO-SAN PEDRO JM, GONZALEZ-POLO RA, FUENTES JM, NISO-SANTANO M. ER-mitochondria signaling in Parkinson’s disease. Cell Death Dis. 2018;9:337. doi: 10.1038/s41419-017-0079-3. PubMed DOI PMC

GONATAS NK, STIEBER A, GONATAS JO. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J Neurol Sci. 2006;246:21–30. doi: 10.1016/j.jns.2006.01.019. PubMed DOI

GUARDIA-LAGUARTA C, AREA-GOMEZ E, RUB C, LIU Y, MAGRANE J, BECKER D, VOOS W, SCHON EA, PRZEDBORSKI S. alpha-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci. 2014;34:249–259. doi: 10.1523/JNEUROSCI.2507-13.2014. PubMed DOI PMC

GUYENET PG, BAYLISS DA. Neural control of breathing and CO2 homeostasis. Neuron. 2015;87:946–961. doi: 10.1016/j.neuron.2015.08.001. PubMed DOI PMC

HASHIMOTO M, HSU LJ, XIA Y, TAKEDA A, SISK A, SUNDSMO M, MASLIAH E. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport. 1999;10:717–721. doi: 10.1097/00001756-199903170-00011. PubMed DOI

HERER B, ARNULF I, HOUSSET B. Effects of levodopa on pulmonary function in Parkinson’s disease. Chest. 2001;119:387–393. doi: 10.1378/chest.119.2.387. PubMed DOI

HOEHN MM, YAHR MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442. doi: 10.1212/WNL.17.5.427. PubMed DOI

HOVESTADT A, BOGAARD JM, MEERWALDT JD, van der MECHE FG, STIGT J. Pulmonary function in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1989;52:329–333. doi: 10.1136/jnnp.52.3.329. PubMed DOI PMC

IZQUIERDO-ALONSO JL, JIMENEZ-JIMENEZ FJ, CABRERA-VALDIVIA F, MANSILLA-LESMES M. Airway dysfunction in patients with Parkinson’s disease. Lung. 1994;172:47–55. doi: 10.1007/BF00186168. PubMed DOI

JAHROUDI N, KITNEY J, GREENBERGER JS, BOWSER R. Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein. J Neurosci Res. 1998;54:828–839. doi: 10.1002/(SICI)1097-4547(19981215)54:6<828::AID-JNR11>3.0.CO;2-M. PubMed DOI

KORPÁS J, TOMORI Z. Cough and other respiratory reflexes. Vol. 12. Karger; Basel: 1979. p. 356.

LI CH, CHEN WC, LIAO WC, TU CY, LIN CL, SUNG FC, CHEN CH, HSU WH. The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide population-based retrospective cohort study. QJM. 2015;108:39–45. doi: 10.1093/qjmed/hcu136. PubMed DOI

LIMA JC, OLIVEIRA LM, BOTELHO MT, MOREIRA TS, TAKAKURA AC. The involvement of the pathway connecting the substantia nigra, the periaqueductal gray matter and the retrotrapezoid nucleus in breathing control in a rat model of Parkinson’s disease. Exp Neurol. 2018;302:46–56. doi: 10.1016/j.expneurol.2018.01.003. PubMed DOI

MULKEY DK, STORNETTA RL, WESTON MC, SIMMONS JR, PARKER A, BAYLISS DA, GUYENET PG. Respiratory control by ventral surface chemoreceptor neurons in rats. Nat Neurosci. 2004;7:1360–1369. doi: 10.1038/nn1357. PubMed DOI

NAKAGOMI S, BARSOUM MJ, BOSSY-WETZEL E, SUTTERLIN C, MALHOTRA V, LIPTON SA. A Golgi fragmentation pathway in neurodegeneration. Neurobiol Dis. 2008;29:221–231. doi: 10.1016/j.nbd.2007.08.015. PubMed DOI PMC

NEMANI VM, LU W, BERGE V, NAKAMURA K, ONOA B, LEE MK, CHAUDHRY FA, NICOLL RA, EDWARDS RH. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65:66–79. doi: 10.1016/j.neuron.2009.12.023. PubMed DOI PMC

NEU HC, CONNOLLY JJ, jr, SCHWERTLEY FW, LADWIG HA, BRODY AW. Obstructive respiratory dysfunction in parkinsonian patients. Am Rev Respir Dis. 1967;95:33–47. doi: 10.1164/arrd.1967.95.1.33. PubMed DOI

NGUYEN M, WONG YC, YSSELSTEIN D, SEVERINO A, KRAINC D. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci. 2019;42:140–149. doi: 10.1016/j.tins.2018.11.001. PubMed DOI PMC

OBENOUR WH, STEVENS PM, COHEN AA, McCUTCHEN JJ. The causes of abnormal pulmonary function in Parkinson’s disease. Am Rev Respir Dis. 1972;105:382–387. doi: 10.1164/arrd.1972.105.3.382. PubMed DOI

OLIVEIRA LM, FALQUETTO B, MOREIRA TS, TAKAKURA AC. Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson’s disease model. Exp Neurol. 2018;309:107–118. doi: 10.1016/j.expneurol.2018.08.004. PubMed DOI

OLIVEIRA LM, OLIVEIRA MA, MORIYA HT, MOREIRA TS, TAKAKURA AC. Respiratory disturbances in a mouse model of Parkinson’s disease. Exp Physiol. 2019;104:729–739. doi: 10.1113/EP087507. PubMed DOI

OLIVEIRA LM, TUPPY M, MOREIRA TS, TAKAKURA AC. Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson’s disease model. Exp Neurol. 2017;293:172–180. doi: 10.1016/j.expneurol.2017.04.006. PubMed DOI

OMURA T, KANEKO M, OKUMA Y, MATSUBARA K, NOMURA Y. Endoplasmic reticulum stress and Parkinson’s disease: the role of HRD1 in averting apoptosis in neurodegenerative disease. Oxid Med Cell Longev. 2013;2013:239854. doi: 10.1155/2013/239854. PubMed DOI PMC

ONODERA H, OKABE S, KIKUCHI Y, TSUDA T, ITOYAMA Y. Impaired chemosensitivity and perception of dyspnea in Parkinson’s disease. Lancet. 2000;356:739–740. doi: 10.1016/S0140-6736(00)02638-6. PubMed DOI

PAL PK, SATHYAPRABHA TN, TUHINA P, THENNARASU K. Pattern of subclinical pulmonary dysfunctions in Parkinson’s disease and the effect of levodopa. Mov Disord. 2007;22:420–424. doi: 10.1002/mds.21330. PubMed DOI

PARK JS, DAVIS RL, SUE CM. Mitochondrial Dysfunction in Parkinson’s disease: New mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep. 2018;18:21. doi: 10.1007/s11910-018-0829-3. PubMed DOI PMC

PARKINSON J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14:223–236. doi: 10.1176/jnp.14.2.223. discussion 222. PubMed DOI

PARSHALL MB, SCHWARTZSTEIN RM, ADAMS L, BANZETT RB, MANNING HL, BOURBEAU J, CALVERLEY PM, GIFT AG, HARVER A, LAREAU SC, MAHLER DA, MEEK PM, O’DONNELL DE AMERICAN THORACIC SOCIETY COMMITTEE ON D. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–452. doi: 10.1164/rccm.201111-2042ST. PubMed DOI PMC

PAULSON GD, TAFRATE RH. Some “minor” aspects of parkinsonism, especially pulmonary function. Neurology. 1970;20:14–17. doi: 10.1212/WNL.20.12_Part_2.14. PubMed DOI

PERFEITO R, CUNHA-OLIVEIRA T, REGO AC. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med. 2012;53:1791–1806. doi: 10.1016/j.freeradbiomed.2012.08.569. PubMed DOI

PHILLIPS RJ, BILLINGSLEY CN, POWLEY TL. Macrophages are unsuccessful in clearing aggregated alpha-synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats. Anat Rec (Hoboken) 2013;296:654–669. doi: 10.1002/ar.22675. PubMed DOI PMC

ROTA L, PELLEGRINI C, BENVENUTI L, ANTONIOLI L, FORNAI M, BLANDIZZI C, CATTANEO A, COLLA E. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8:5. doi: 10.1186/s40035-019-0146-z. PubMed DOI PMC

SABATE M, GONZALEZ I, RUPEREZ F, RODRIGUEZ M. Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. J Neurol Sci. 1996;138:114–119. doi: 10.1016/0022-510X(96)00003-2. PubMed DOI

SAKURAI T. Regulatory mechanism of sleep/wakefulness states by orexin. Tanpakushitsu Kakusan Koso. 2007;52:1840–1848. PubMed

SATHYAPRABHA TN, KAPAVARAPU PK, PALL PK, THENNARASU K, RAJU TR. Pulmonary functions in Parkinson’s disease. Indian J Chest Dis Allied Sci. 2005;47:251–257. PubMed

SECCOMBE LM, GIDDINGS HL, ROGERS PG, CORBETT AJ, HAYES MW, PETERS MJ, VEITCH EM. Abnormal ventilatory control in Parkinson’s disease--further evidence for non-motor dysfunction. Respir Physiol Neurobiol. 2011;179:300–304. doi: 10.1016/j.resp.2011.09.012. PubMed DOI

SHILL H, STACY M. Respiratory complications of Parkinson’s disease. Semin Respir Crit Care Med. 2002;23:261–265. doi: 10.1055/s-2002-33034. PubMed DOI

SIMUNI T, SETHI K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol. 2008;64(Suppl 2):S65–S80. doi: 10.1002/ana.21472. PubMed DOI

SUAREZ AA, PESSOLANO FA, MONTEIRO SG, FERREYRA G, CAPRIA ME, MESA L, DUBROVSKY A, DE VITO EL. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002;81:506–511. doi: 10.1097/00002060-200207000-00007. PubMed DOI

TAKAKURA AC, MOREIRA TS, COLOMBARI E, WEST GH, STORNETTA RL, GUYENET PG. Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO2-sensitive neurons in rats. J Physiol. 2006;572:503–523. doi: 10.1113/jphysiol.2005.103788. PubMed DOI PMC

TAMO W, IMAIZUMI T, TANJI K, YOSHIDA H, MORI F, YOSHIMOTO M, TAKAHASHI H, FUKUDA I, WAKABAYASHI K, SATOH K. Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer’s disease amyloid, in human cerebral blood vessels. Neurosci Lett. 2002;326:5–8. doi: 10.1016/S0304-3940(02)00297-5. PubMed DOI

TORSNEY KM, FORSYTH D. Respiratory dysfunction in Parkinson’s disease. J R Coll Physicians Edinb. 2017;47:35–39. doi: 10.4997/JRCPE.2017.108. PubMed DOI

TUPPY M, BARNA BF, ALVES-DOS-SANTOS L, BRITTO LR, CHIAVEGATTO S, MOREIRA TS, TAKAKURA AC. Respiratory deficits in a rat model of Parkinson’s disease. Neuroscience. 2015;297:194–204. doi: 10.1016/j.neuroscience.2015.03.048. PubMed DOI

TZELEPIS GE, MCCOOL FD, FRIEDMAN JH, HOPPIN FG., JR Respiratory muscle dysfunction in Parkinson’s disease. Am Rev Respir Dis. 1988;138:266–271. doi: 10.1164/ajrccm/138.2.266. PubMed DOI

VINCKEN WG, GAUTHIER SG, DOLLFUSS RE, HANSON RE, DARAUAY CM, COSIO MG. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med. 1984;311:438–442. doi: 10.1056/NEJM198408163110704. PubMed DOI

WANG T, HAY JC. Alpha-synuclein toxicity in the early secretory pathway: how it drives neurodegeneration in Parkinsons disease. Front Neurosci. 2015;9:433. doi: 10.3389/fnins.2015.00433. PubMed DOI PMC

WANG Y, SHAO WB, GAO L, LU J, GU H, SUN LH, TAN Y, ZHANG YD. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson’s disease and multiple system atrophy--comparison with normal elderly. PLoS One. 2014;9:e116123. doi: 10.1371/journal.pone.0116123. PubMed DOI PMC

WEIDNER J, JARENBACK L, ABERG I, WESTERGREN-THORSSON G, ANKERST J, BJERMER L, TUFVESSON E. Endoplasmic reticulum, Golgi, and lysosomes are disorganized in lung fibroblasts from chronic obstructive pulmonary disease patients. Physiol Rep. 2018;6:e13584. doi: 10.14814/phy2.13584. PubMed DOI PMC

WEINER WJ, GOETZ CG, NAUSIEDA PA, KLAWANS HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med. 1978;88:327–331. doi: 10.7326/0003-4819-88-3-327. PubMed DOI

WILLIAMS RH, BURDAKOV D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med. 2008;10:e28. doi: 10.1017/S1462399408000823. PubMed DOI PMC

WILLIAMS RH, JENSEN LT, VERKHRATSKY A, FUGGER L, BURDAKOV D. Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A. 2007;104:10685–10690. doi: 10.1073/pnas.0702676104. PubMed DOI PMC

Legacy of Prof. Juraj Korpáš: International Impact of Slovak School of Experimental Respirology